UBS on Friday downgraded Xpeng Inc (NYSE:XPEV) to “sell” from “neutral” as it views the stock’s rally has overextended and downside risks are not fully reflected in the current valuation.
James initiated coverage on Abercrombie&Fitch with an Outperform rating and a $180 price target, citing substantial progress in the company's ongoing transformation.
Some results have been hidden because they may be inaccessible to you